Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 050207

Expand all

E.E.S. (ERYTHROMYCIN ETHYLSUCCINATE)
EQ 200MG BASE/5ML
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN ETHYLSUCCINATE
Proprietary Name: E.E.S.
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: EQ 200MG BASE/5ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N050207
Product Number: 001
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CARNEGIE PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ERYPED (ERYTHROMYCIN ETHYLSUCCINATE)
EQ 200MG BASE/5ML
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN ETHYLSUCCINATE
Proprietary Name: ERYPED
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: EQ 200MG BASE/5ML
Reference Listed Drug: Yes
Reference Standard: No
TE Code: AB
Application Number: N050207
Product Number: 003
Approval Date: Mar 30, 1987
Applicant Holder Full Name: CARNEGIE PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information

ERYPED (ERYTHROMYCIN ETHYLSUCCINATE)
EQ 400MG BASE/5ML
Marketing Status: Prescription

Active Ingredient: ERYTHROMYCIN ETHYLSUCCINATE
Proprietary Name: ERYPED
Dosage Form; Route of Administration: GRANULE; ORAL
Strength: EQ 400MG BASE/5ML
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: AB
Application Number: N050207
Product Number: 002
Approval Date: Approved Prior to Jan 1, 1982
Applicant Holder Full Name: CARNEGIE PHARMACEUTICALS LLC
Marketing Status:  Prescription
Patent and Exclusivity Information